SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001827506-24-000083
Filing Date
2024-09-11
Accepted
2024-09-11 16:18:39
Documents
14
Period of Report
2024-09-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K trml-20240905.htm   iXBRL 8-K 32872
2 EX-3.1 exhibit31.htm EX-3.1 152619
  Complete submission text file 0001827506-24-000083.txt   354785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20240905.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20240905_lab.xml EX-101.LAB 24352
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20240905_pre.xml EX-101.PRE 14128
16 EXTRACTED XBRL INSTANCE DOCUMENT trml-20240905_htm.xml XML 3015
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 241292858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)